Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New glucocorticoid receptor antagonists discovered at ORIC Pharmaceuticals

April 29, 2020

Interim phase I data for ATOR-1015 presented by Alligator Bioscience

April 29, 2020

First prospective peek at Thrive's Cancerseek reveals gaps in liquid biopsy testing

April 29, 2020

Regenacy Pharmaceuticals discloses new HDAC1/HDAC2 inhibitors

April 29, 2020

Phase III VOYAGER study of avapritinib does not meet primary endpoint

April 29, 2020

Preclinical evaluation of the survivin inhibitor FL-118 in relapsed/refractory multiple myeloma

April 29, 2020

BXCL-701 advances into phase II portion of phase Ib/II trial with pembrolizumab for tNEPC

April 28, 2020

AACR 2020: Phosphatases are yin to kinases' yang

April 28, 2020

New TLR7 agonist prodrugs disclosed by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

April 28, 2020

NantBioScience patents dual Wnt/beta-catenin and hedgehog signaling inhibitors

April 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...